Literature DB >> 10203434

Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants.

M Fox1, M Molesky, J E Van Aerde, S Muttitt.   

Abstract

OBJECTIVE: To determine whether changing total parenteral nutrition fluid administration sets (TAS) every 48 h rather than every 24 h results in a greater infusate contamination rate. PATIENTS AND METHODS: Prospectively, 166 infants were assigned at random to have TAS changed either every 24 h or every 48 h. Samples of the infusate were cultured to determine contamination rates of the infusate in the sets and were tested from 149 of these infants. TAS was replaced every 24 h in the control group, and 445 amino acid plus dextrose solutions (AADS) and 449 lipid emulsions samples were taken for bacterial culture. Fungal cultures were also performed on 449 samples. The study group had TAS replaced every 48 h, and 454 samples of AADS were cultured for bacteria. The numbers of lipid emulsion samples sent for bacterial culture and fungal culture were 449 and 440, respectively. Information on type of intravenous access device, administration of antibiotics and blood cultures was also collected.
RESULTS: There was no difference in bacterial contamination rates for AADS or lipid emulsion from TAS changed every 24 or 48 h (c2, P>0.05). Lipid emulsion sampled from the 24 h group showed a statistically significant higher rate of fungal contamination than specimens from the 48 h group (P<0.01).
CONCLUSIONS: Changing TAS every 48 h versus 24 h does not increase the contamination rate of infusate in newborns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203434     DOI: 10.1155/1999/160897

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  6 in total

Review 1.  Does decreasing the frequency of changing intravenous administration sets (>24 h) increase the incidence of sepsis in neonates receiving total parenteral nutrition?

Authors:  Nevart Chirinian; Vibhuti Shah
Journal:  Paediatr Child Health       Date:  2012-11       Impact factor: 2.253

Review 2.  Optimal timing for intravascular administration set replacement.

Authors:  Amanda J Ullman; Marie L Cooke; Donna Gillies; Nicole M Marsh; Azlina Daud; Matthew R McGrail; Elizabeth O'Riordan; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2013-09-15

3.  Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial).

Authors:  Claire M Rickard; Nicole M Marsh; Joan Webster; Nicole C Gavin; Matthew R McGrail; Emily Larsen; Amanda Corley; Debbie Long; John R Gowardman; Marghie Murgo; John F Fraser; Raymond J Chan; Marianne C Wallis; Jeanine Young; David McMillan; Li Zhang; Md Abu Choudhury; Nicholas Graves; E Geoffrey Playford
Journal:  BMJ Open       Date:  2015-02-03       Impact factor: 2.692

4.  Standardised neonatal parenteral nutrition formulations - Australasian neonatal parenteral nutrition consensus update 2017.

Authors:  Srinivas Bolisetty; David Osborn; Tim Schindler; John Sinn; Girish Deshpande; Chee Sing Wong; Susan E Jacobs; Nilkant Phad; Pramod Pharande; Rodney Tobiansky; Melissa Luig; Amit Trivedi; Joanne Mcintosh; Eszter Josza; Gillian Opie; Lyn Downe; Chad Andersen; Vineesh Bhatia; Prasanna Kumar; Katri Malinen; Pita Birch; Karen Simmer; Gemma McLeod; Suzanne Quader; Victor Samuel Rajadurai; Michael Patrick Hewson; Arun Nair; Megan Williams; Jing Xiao; Hari Ravindranathan; Roland Broadbent; Kei Lui
Journal:  BMC Pediatr       Date:  2020-02-08       Impact factor: 2.125

Review 5.  Lipid emulsions - Guidelines on Parenteral Nutrition, Chapter 6.

Authors:  M Adolph; A R Heller; T Koch; B Koletzko; K G Kreymann; K Krohn; E Pscheidl; M Senkal
Journal:  Ger Med Sci       Date:  2009-11-18

6.  Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012.

Authors:  Srinivas Bolisetty; David Osborn; John Sinn; Kei Lui
Journal:  BMC Pediatr       Date:  2014-02-18       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.